Center receives biodefense patent

March 09, 2003

Researchers at the Edgewood Chemical Biological Center have obtained a patent with applications for biological-agent detection technology, the research center reports.

The patent, which was awarded Dec. 31, involves a new spectroscopic method for the diagnosis of DNA damage. The procedure can be implemented with equipment used to detect the presence of biological weapons on battlefields.

"This patent represents the hard work and dedication of our employees," said Jim Zarzycki, technical director of the Edgewood center. "We expend serious amounts of effort to build our nation's chemical and biological defense capabilities. This patent is proof of our solid, novel approaches."

Scientists from the center's research and technology directorate combined with personnel from the Army Research Office and the Stephens Institute of Technology in the work leading to the patent.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.